Rise in prevalence of respiratory diseases and increase in demand for minimally invasive surgeries are fostering the nasal polyps treatment market size.
Nasal polyps treatment includes corticosteroids, antihistamines, decongestants, saline irrigation, biologics, or surgery for symptom relief and polyp reduction.
Rapid growth in pollution is causing respiratory issues among geriatric population and children, thereby boosting market expansion.
Leading players in the industry are investing in technological advancements to provide effective treatments to the patients.
Companies are developing new drugs by seeking funding from multiple investors to enhance their product portfolio. Moreover, they are conducting clinical trials to ensure effectiveness and efficiency of the drugs developed.
Nasal polyps are noncancerous growths that develop in the lining of the nose or sinuses. They are typically soft and painless and result from chronic inflammation due to conditions, such as allergies, asthma, or recurring infections.
The treatment of nasal polyps typically involves a combination of medical therapies and, in some cases, surgical intervention. Nasal corticosteroids, systemic corticosteroids, antihistamines, decongestants, saline nasal irrigation, biologic therapies, and surgery are some of the common nose polyps treatments.
Nasal polyps can be treated efficiently if diagnosed at an early stage. Symptom relief, complication prevention, enhancement of sense of smell, and medication customization are major applications of nasal polyps treatment.
Nasal polyps can impact an individual's quality of life by causing discomfort, affecting sleep, impairing physical activity, and reducing productivity. Treatment aims to improve quality of life by relieving symptoms, restoring normal nasal function, and enhancing overall well-being.
| Attribute | Detail |
|---|---|
| Drivers |
|
Urbanization and industrialization across the globe are causing pollution due to construction activities and other environmental factors. Asthma, chronic rhinosinusitis, allergies, and pollutants can cause nasal polyps.
These factors are likely to affect significantly among the elderly population and children. Negligence to the symptoms at initial stage can lead to severe respiratory diseases. Thus, rise in prevalence of respiratory diseases is fueling market dynamics.
Growth in pollution and rise in demand for nasal polyps therapy are major nasal polyps treatment market drivers. Steroid nasal sprays for nasal polyps help relieve pain and discomfort while sleeping due to respiratory diseases.
According to the data published by the Global Asthma Network in 2022, there were around 262 million people affected by asthma worldwide. Approximately 454.6 million people globally suffer from chronic respiratory diseases.
Minimally invasive procedures offer several advantages over traditional open surgeries, particularly for nasal polyps. Minimally invasive surgeries for nasal polyps typically involve smaller incisions, leading to less tissue trauma and quicker recovery times.
Endoscopic sinus surgery involves a lower risk of complications, such as scarring, bleeding, and infection. Many patients prefer minimally invasive approaches for nasal polyps treatment due to shorter recovery times, less pain, and lower risk of complications.
Thus, increase in demand for minimally invasive surgeries is furling the nasal polyps treatment market revenue.
Advancements in surgical techniques, instrumentation, and imaging technology have made minimally invasive procedures for nasal polyps more precise, effective, and accessible.
Endoscopic Sinus Surgery (ESS) allows surgeons to visualize and remove nasal polyps using small, flexible endoscopes, minimizing tissue damage and maximizing surgical outcomes. Hence, technological advancements in medical equipment and surgeries are bolstering market progress.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest nasal polyps treatment market insights, North America dominated the global market in 2022. Rise in prevalence of chronic rhinosinusitis with nasal polyps among the population is likely to propel the nasal polyps treatment industry share during the forecast period.
Moreover, increase in number of sinus surgeries performed in the U.S. is augmenting market development.
According to the Centers for Disease Control and Prevention, approximately 28.9 million adults have been diagnosed with sinusitis, which accounts for about 11.6% of the adult population in the U.S. Moreover, there were around 2.7 million visits to physician offices with chronic sinusitis as the primary diagnosis.
As per the recent nasal polyps treatment market trends, new nasal polyps treatment advancements and technological developments in medical settings allow companies to introduce new drugs and treatments.
Leading players in the market adopt multiple strategies including acquisitions and partnerships to increase their investments in product development. Moreover, they are conducting various clinical trials to evaluate product quality and efficiency.
Some of the players in the industry are Sanofi, Merck & Co, Inc., OptiNose US, Inc., Intersect ENT, Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Novartis AG, GSK plc., and F. Hoffmann-La Roche Ltd.
These companies have been profiled in the nasal polyps treatment market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 4.5 Bn |
| Market Forecast (Value) in 2031 | US$ 7.5 Bn |
| Growth Rate (CAGR) | 5.7% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 4.5 Bn in 2022
It is projected to register a CAGR of 5.7% from 2023 to 2031
Rise in prevalence of respiratory diseases and increase in demand for minimally invasive surgeries
North America was the most lucrative region in 2022
Sanofi, Merck & Co, Inc., OptiNose US, Inc., Intersect ENT, Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Novartis AG, GSK plc., and F. Hoffmann-La Roche Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nasal Polyps Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nasal Polyps Treatment Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Nasal Polyps Treatment Market Analysis and Forecast, by Type of Treatment
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type of Treatment, 2017-2031
6.3.1. Pharmacological Therapies
6.3.1.1. Corticosteroids
6.3.1.2. Antibiotics
6.3.1.3. Leukotriene Inhibitors
6.3.1.4. Others
6.3.2. Surgeries
6.3.2.1. Polypectomy
6.3.2.2. Functional Endoscopic Sinus Surgery (FESS)
6.4. Market Attractiveness Analysis, by Type of Treatment
7. Global Nasal Polyps Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Specialty Clinics
7.4. Market Attractiveness Analysis, by End-user
8. Global Nasal Polyps Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017-2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Nasal Polyps Treatment Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Type of Treatment, 2017-2031
9.3.1. Pharmacological Therapies
9.3.1.1. Corticosteroids
9.3.1.2. Antibiotics
9.3.1.3. Leukotriene Inhibitors
9.3.1.4. Others
9.3.2. Surgeries
9.3.2.1. Polypectomy
9.3.2.2. Functional Endoscopic Sinus Surgery (FESS)
9.4. Market Value Forecast, by End-user, 2017-2031
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. Specialty Clinics
9.5. Market Value Forecast, by Country, 2017-2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Type of Treatment
9.6.2. By End-user
9.6.3. By Country
10. Europe Nasal Polyps Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type of Treatment, 2017-2031
10.3.1. Pharmacological Therapies
10.3.1.1. Corticosteroids
10.3.1.2. Antibiotics
10.3.1.3. Leukotriene Inhibitors
10.3.1.4. Others
10.3.2. Surgeries
10.3.2.1. Polypectomy
10.3.2.2. Functional Endoscopic Sinus Surgery (FESS)
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Specialty Clinics
10.5. Market Value Forecast, by Country/Sub-region, 2017-2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Type of Treatment
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Nasal Polyps Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type of Treatment, 2017-2031
11.3.1. Pharmacological Therapies
11.3.1.1. Corticosteroids
11.3.1.2. Antibiotics
11.3.1.3. Leukotriene Inhibitors
11.3.1.4. Others
11.3.2. Surgeries
11.3.2.1. Polypectomy
11.3.2.2. Functional Endoscopic Sinus Surgery (FESS)
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Specialty Clinics
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Type of Treatment
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Nasal Polyps Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type of Treatment, 2017-2031
12.3.1. Pharmacological Therapies
12.3.1.1. Corticosteroids
12.3.1.2. Antibiotics
12.3.1.3. Leukotriene Inhibitors
12.3.1.4. Others
12.3.2. Surgeries
12.3.2.1. Polypectomy
12.3.2.2. Functional Endoscopic Sinus Surgery (FESS)
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Specialty Clinics
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Type of Treatment
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Nasal Polyps Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type of Treatment, 2017-2031
13.3.1. Pharmacological Therapies
13.3.1.1. Corticosteroids
13.3.1.2. Antibiotics
13.3.1.3. Leukotriene Inhibitors
13.3.1.4. Others
13.3.2. Surgeries
13.3.2.1. Polypectomy
13.3.2.2. Functional Endoscopic Sinus Surgery (FESS)
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Specialty Clinics
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Type of Treatment
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Sanofi
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Merck & Co, Inc.
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. OptiNose US, Inc.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Intersect ENT, Inc.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Pfizer Inc.
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Regeneron Pharmaceuticals Inc.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Novartis AG
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. GSK plc.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. F. Hoffmann-La Roche Ltd
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
List of Tables
Table 01: Global Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Type of Treatment, 2017-2031
Table 02: Global Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 03: Global Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Country, 2017-2031
Table 05: North America Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Type of Treatment, 2017-2031
Table 06: North America Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Europe Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 08: Europe Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Type of Treatment, 2017-2031
Table 09: Europe Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 10: Asia Pacific Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 11: Asia Pacific Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Type of Treatment, 2017-2031
Table 12: Asia Pacific Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Latin America Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Latin America Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Type of Treatment, 2017-2031
Table 15: Latin America Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Middle East & Africa Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Middle East & Africa Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by Type of Treatment, 2017-2031
Table 18: Middle East & Africa Nasal Polyps Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Nasal Polyps Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
Figure 02: Global Nasal Polyps Treatment Market Revenue (US$ Mn), by Type of Treatment, 2022
Figure 03: Global Nasal Polyps Treatment Market Value Share, by Type of Treatment, 2022
Figure 04: Global Nasal Polyps Treatment Market Revenue (US$ Mn), by End-user, 2022
Figure 05: Global Nasal Polyps Treatment Market Value Share, by End-user, 2022
Figure 06: Global Nasal Polyps Treatment Market Value Share, by Region, 2022
Figure 07: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, 2023-2031
Figure 08: Global Nasal Polyps Treatment Market Value Share Analysis, by Type of Treatment, 2022-2031
Figure 09: Global Nasal Polyps Treatment Market Attractiveness Analysis, by Type of Treatment, 2023-2031
Figure 10: Global Nasal Polyps Treatment Market Value Share Analysis, by End-user, 2022-2031
Figure 11: Global Nasal Polyps Treatment Market Attractiveness Analysis, by End-user, 2023-2031
Figure 12: Global Nasal Polyps Treatment Market Value Share Analysis, by Region, 2022-2031
Figure 13: Global Nasal Polyps Treatment Market Attractiveness Analysis, by Region, 2023-2031
Figure 14: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 15: North America Nasal Polyps Treatment Market Attractiveness Analysis, by Country, 2023-2031
Figure 16: North America Nasal Polyps Treatment Market Value Share Analysis, by Country, 2022-2031
Figure 17: North America Nasal Polyps Treatment Market Value Share Analysis, by Type of Treatment, 2022-2031
Figure 18: North America Nasal Polyps Treatment Market Value Share Analysis, by End-user, 2022-2031
Figure 19: North America Nasal Polyps Treatment Market Attractiveness Analysis, by Type of Treatment, 2023-2031
Figure 20: North America Nasal Polyps Treatment Market Attractiveness Analysis, by End-user, 2023-2031
Figure 21: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 22: Europe Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 23: Europe Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
Figure 24: Europe Nasal Polyps Treatment Market Value Share Analysis, by Type of Treatment, 2022-2031
Figure 25: Europe Nasal Polyps Treatment Market Value Share Analysis, by End-user, 2022-2031
Figure 26: Europe Nasal Polyps Treatment Market Attractiveness Analysis, by Type of Treatment, 2023-2031
Figure 27: Europe Nasal Polyps Treatment Market Attractiveness Analysis, by End-user, 2023-2031
Figure 28: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 29: Asia Pacific Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 30: Asia Pacific Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
Figure 31: Asia Pacific Nasal Polyps Treatment Market Value Share Analysis, by Type of Treatment, 2022-2031
Figure 32: Asia Pacific Nasal Polyps Treatment Market Value Share Analysis, by End-user, 2022-2031
Figure 33: Asia Pacific Nasal Polyps Treatment Market Attractiveness Analysis, by Type of Treatment, 2023-2031
Figure 34: Asia Pacific Nasal Polyps Treatment Market Attractiveness Analysis, by End-user, 2023-2031
Figure 35: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 36: Latin America Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 37: Latin America Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
Figure 38: Latin America Nasal Polyps Treatment Market Value Share Analysis, by Type of Treatment, 2022-2031
Figure 39: Latin America Nasal Polyps Treatment Market Value Share Analysis, by End-user, 2022-2031
Figure 40: Latin America Nasal Polyps Treatment Market Attractiveness Analysis, by Type of Treatment, 2023-2031
Figure 41: Latin America Nasal Polyps Treatment Market Attractiveness Analysis, by End-user, 2023-2031
Figure 42: Middle East & Africa Nasal Polyps Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 43: Middle East & Africa Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 44: Middle East & Africa Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
Figure 45: Middle East & Africa Nasal Polyps Treatment Market Value Share Analysis, by Type of Treatment, 2022-2031
Figure 46: Middle East & Africa Nasal Polyps Treatment Market Value Share Analysis, by End-user, 2022-2031
Figure 47: Middle East & Africa Nasal Polyps Treatment Market Attractiveness Analysis, by Type of Treatment, 2023-2031
Figure 48: Middle East & Africa Nasal Polyps Treatment Market Attractiveness Analysis, by End-user, 2023-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Nasal Polyps Treatment Market
*86 figures and 60 tables includes